Revance Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Barclays
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $14k | 19k | 0.74 |
2023-09-30 | $1.2M | 1.5M | 0.80 |